DNMT3A and acute myeloid leukemia: Mutations of DNMT3A are prevalent in hematological cancers such as acute myeloid leukemia (AML)20 and occur in a developmental overgrowth syndrome21; in contrast, mutations of DNMT3B lead to the Immunodeficiency, centromeric instability, facial anomalies (ICF) syndrome5,22–24.